COMMUNIQUÉS West-GlobeNewswire

Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-501 Oral in Patients with Alopecia Areata Met Primary Endpoint
30/07/2019
ATI-501 achieved statistically significant improvement over placebo in several measures of hair growth, including the primary endpoint and certain secondary endpoints of the trial. ATI-501 was generally well-tolerated [...]
Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2019 Financial and Operating Results
30/07/2019
BOTHELL, Wash., July 30, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Alphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock
30/07/2019
CARLSBAD, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today [...]
T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update
30/07/2019
Announces Two Financing Agreements to Potentially Provide up to $60 Million of Additional Capital; Reducing Cash Burn by 30% by Q4 2019 Achieved $1.8 Million in Total Revenue and Secured 12 New T2Dx® Instrument [...]
Rheumatology Leaders Applaud Updates to Evaluation and Management Codes in CMS 2020 Physician Fee Schedule Proposed Rule
30/07/2019
Proposed Coding Changes Recognize Value of Time Spent with Complex Patients Atlanta, July 30, 2019 (GLOBE NEWSWIRE) -- WASHINGTON, D.C. – The American College of Rheumatology (ACR) today applauded the Centers for [...]
CV Sciences, Inc. Announces Expanded Distribution Partnership With The Kroger Co.
30/07/2019
PlusCBD™ Oil Topicals Now Available at 1,350 Kroger Stores SAN DIEGO, July 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and [...]
Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019
30/07/2019
BOCA RATON, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological [...]
Update - Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July
30/07/2019
SOUTH ORANGE, NJ, July 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPHD), a commercial-stage company that develops and sells high performance water purification products to the medical device [...]
Lexicon Pharmaceuticals Announces Date Change for Second Quarter 2019 Financial Results Conference Call and Webcast to July 31, 2019
30/07/2019
THE WOODLANDS, Texas, July 30, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that it has changed the date of its previously announced earnings release, conference call and [...]
CV Sciences, Inc. Applauds Ohio’s State Law Passage of Senate Bill 57
30/07/2019
Senate Bill 57 Legalizes Hemp Cultivation and CBD Sales in Ohio SAN DIEGO, July 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and [...]
LeMaitre Vascular to Present at the Canaccord Genuity Annual Growth Conference on Thursday, August 8, 2019
30/07/2019
BURLINGTON, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 39 th Annual Growth [...]
“Canada can lead the world”: New MHCC cannabis research points the way forward
30/07/2019
OTTAWA, July 30, 2019 (GLOBE NEWSWIRE) -- From Mental Health Commission of Canada Today, the Mental Health Commission of Canada (MHCC), in collaboration with the University of Calgary, released an important report, [...]
« Le Canada comme chef de file » : Une nouvelle recherche de la CSMC sur le cannabis indique la voie à suivre
30/07/2019
OTTAWA, 30 juill. 2019 (GLOBE NEWSWIRE) -- De Commission de la santé mentale du Canada En collaboration avec l’Université de Calgary, la Commission de la santé mentale du Canada (CSMC) publie aujourd’hui un important [...]
Inventiva - H1 2019 Financial Information and Corporate Business Update
30/07/2019
H1 2019 1 Financial Information and Corporate Business Update Cash and cash equivalents of €37.1m as at June 30, 2019, in line with expectations H1 revenues at €1.2m Significant progress in NASH program, notably in the [...]
Inventiva - Information financière du 1er semestre 2019 et point sur l’activité
30/07/2019
Information financière du 1 er semestre 2019 1 et point sur l’activité Trésorerie et équivalents de trésorerie à 37,1 M€ au 30 juin 2019, conformément aux prévisions Chiffre d’affaires du semestre de 1,2 M€ Progrès [...]
SoldierStrong, Department of Veterans Affairs Partner to Treat Post-Traumatic Stress With Virtual Reality Systems
30/07/2019
STAMFORD, Conn., July 30, 2019 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing advanced medical technologies to veterans, and the Department of Veterans Affairs have signed a [...]
Ziopharm Oncology to Host Conference Call to Discuss Second Quarter 2019 Results on August 8, 2019
30/07/2019
BOSTON, July 30, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that management will host a conference call and webcast on Thursday, August 8, at 8:30 a.m. ET to provide a corporate [...]
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2019
30/07/2019
SALT LAKE CITY, July 30, 2019 (GLOBE NEWSWIRE) -- In the second calendar quarter (2Q) and first half (1H) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results which reflect that the Company remains on [...]
RESPIRERX PHARMACEUTICALS INC. SEND NOTICE LETTER TO THE BOARD OF DIRECTORS OF THERAPIX BIOSCIENCES LTD.
30/07/2019
Glen Rock, N.J., July 30, 2019 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the research and development of cannabinoids for the treatment of sleep-related [...]

Pages